Non-profit website: free to use. No fees from patients, hospitals or doctors. Not an agency. · Free · Not an agencyLearn more
Hepatobiliary surgery · Peking University Cancer Hospital · Beijing

Dr. Liu Daoning刘道宁

Associate Chief Physician

Summary compiled from public information, updated 18 Nov 2026. It has not been checked against the hospital website yet. Confirm details with the hospital before you travel.

Dr. Liu Daoning

Professional overview

Dr. Liu Daoning is an Associate Chief Physician in the Department of Hepatobiliary and Pancreatic Surgery at Peking University Cancer Hospital. Dr. Liu specializes in comprehensive treatment—including surgery, chemotherapy, targeted therapy, and immunotherapy—for rare retroperitoneal sarcomas, gastrointestinal stromal tumors, pancreatic cancer, hepatocellular carcinoma, colorectal liver metastases, and biliary tract malignancies.

SpecialtyHepatobiliary surgery
Clinical titleAssociate Chief Physician
Academic roles—
DepartmentDepartment of Hepatobiliary and Pancreatic Surgery
HospitalPeking University Cancer Hospital
CityBeijing

Areas of focus

Retroperitoneal liposarcoma
Retroperitoneal leiomyosarcoma
Other rare retroperitoneal soft tissue tumors
Gastrointestinal stromal tumor (GIST)
Pancreatic cancer
Liver cancer
Colorectal cancer liver metastasis
Biliary tract malignancy

Experience & recognition

  • National Gold Award, CLEAP Clinical Practice Competition for Young and Middle-aged Oncologists, Chinese Anti-Cancer Association (CACA)
  • National Third Place, Team Debate Competition on Frontiers and Hot Topics in Hepatocellular Carcinoma Treatment, Chinese Medical Doctor Association (CMDA)
  • 12 first-author publications in SCI journals and international academic conferences
  • Participated in key research projects including Beijing Natural Science Foundation and Beijing Municipal Administration of Hospitals 'Dengfeng Plan' Talent Team Program

Frequently asked questions

What does Dr. Liu Daoning specialize in?

Comprehensive treatment—including surgery, chemotherapy, targeted therapy, and immunotherapy—for retroperitoneal liposarcoma, retroperitoneal leiomyosarcoma, other rare retroperitoneal soft tissue tumors, gastrointestinal stromal tumor, pancreatic cancer, liver cancer, colorectal liver metastases, and biliary tract malignancies.

Which hospital and department is Dr. Liu Daoning in?

Department of Hepatobiliary and Pancreatic Surgery at Peking University Cancer Hospital

Sources

Dr. Liu Daoning has not reviewed this page.